Verrica Pharmaceuticals Inc.
Organization details
- Legal name
- Verrica Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- West Chester
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- VRCA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001660334
- EIN
- 46-3137900
Board of directors
-
Charles Frantzreb · DirectorSince 2025
-
Craig Ballaron · DirectorSince 2023
-
Diem Nguyen · DirectorSince 2023
-
Gavin Corcoran · DirectorSince 2025
-
Jayson Rieger · Director · CEO and PresidentSince 2024
-
John A. Stalfort III · DirectorSince 2024
-
Lawrence Eichenfield · DirectorSince 2023
-
Mark A. Prygocki Sr. · DirectorSince 2023
-
Paul B. Manning · DirectorSince 2023
-
Ted White · Director · PRESIDENT AND CEOSince 2023
Chief executives
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
163.5% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Director election results
Annual meeting of June 5, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.2%
-
99.4%
Board connections
3 of this board's directors also sit on 5 other boards. 5 are in the same sector.
-
Candel Therapeutics Inc. Same sectorvia Diem Nguyen and Paul B. Manning
-
Acumen Pharmaceuticals Inc. Same sectorvia John A. Stalfort III
-
Liquidia Corporation Same sectorvia Paul B. Manning
-
SIGA Technologies Inc. Same sectorvia Diem Nguyen
-
Taysha Gene Therapies Inc. Same sectorvia John A. Stalfort III
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $18,172,997
- 12 purchases by 5 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Kirby John J. Officer (Interim CFO) | Open-market purchase | +5,000 | $4.93 | $24,650 |
| Aug 18, 2026 | Rosenberg Noah L. Officer (CMO) | Open-market purchase | +2,030 | $4.92 | $9,988 |
| Aug 17, 2026 | Rosenberg Noah L. Officer (CMO) | Open-market purchase | +4,200 | $4.91 | $20,622 |
| Aug 17, 2026 | Zawitz David Officer (Chief Operating Officer) | Open-market purchase | +6,000 | $4.98 | $29,880 |
| Aug 17, 2026 | Jayson Rieger Director, Officer (CEO and President) | Open-market purchase | +5,000 | $4.91 | $24,550 |
| Aug 14, 2026 | Jayson Rieger Director, Officer (CEO and President) | Open-market purchase | +20,000 | $5.06 | $101,200 |
| Dec 23, 2025 | Kirby John J. Officer (Interim CFO) | Grant or award | +10,000 | — | — |
| Nov 25, 2025 | Rosenberg Noah L. Officer (CMO) | Open-market purchase | +2,357 | $4.24 | $9,994 |
| Nov 25, 2025 | Kirby John J. Officer (Interim CFO) | Open-market purchase | +3,536 | $4.24 | $14,993 |
| Nov 25, 2025 | Zawitz David Officer (Chief Operating Officer) | Open-market purchase | +10,000 | $4.24 | $42,400 |
| Nov 25, 2025 | Jayson Rieger Director, Officer (CEO and President) | Open-market purchase | +94,311 | $4.24 | $399,879 |
| Nov 25, 2025 | Paul B. Manning Director, 10% owner | Open-market purchase | +1,375,380 | $4.24 | $5,831,611 |
| Nov 25, 2025 | Paul B. Manning Director, 10% owner | Open-market purchase | +2,750,762 | $4.24 | $11,663,231 |
| Mar 17, 2025 | Hayes Christopher G. Officer (CHIEF LEGAL OFFICER) | Open-market sale | −4,315 | $0.65 | $2,805 |
| Nov 26, 2024 | Jayson Rieger Director, Officer (CEO and President) | Gift | +50,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Verrica Pharmaceuticals Inc.
Who is the CEO of Verrica Pharmaceuticals Inc.?
Jayson Rieger has been Verrica Pharmaceuticals Inc.'s CEO and President since November 2024.
How many directors are on Verrica Pharmaceuticals Inc.'s board?
Verrica Pharmaceuticals Inc.'s board has 10 directors: Charles Frantzreb, Craig Ballaron, Diem Nguyen, Gavin Corcoran, Jayson Rieger, John A. Stalfort III, Lawrence Eichenfield, Mark A. Prygocki Sr., Paul B. Manning and Ted White.
Are Verrica Pharmaceuticals Inc. insiders buying or selling shares?
Over the last 12 months, Verrica Pharmaceuticals Inc. insiders bought $18.2 million of shares in 12 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="verrica-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.